China expands centralized procurement and use pilot for drugs

On October 8, the State Medical Security Bureau and other eight departments published opinions on the implementation of expanding the regional scope of drug centralized procurement and use pilot, and carried out 25 general drugs’ centralized procurement and use in 11 pilot cities. All pharmaceutical manufacturers who produces the 25 general drugs (and also Drug Marketing Licenses Holders and general agents of imported drugs) in the mainland of China with the approval of the drug regulatory authorities may participate. Referring to the listed drugs in China, drugs with consistency evaluation of quality and efficacy can be included in the pilot.Read More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is $5,500 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field